Tag: UGT1A

Seminal vesicle invasion predicts decreased survival in bladder cancer

Updated Outcomes of Sacituzumab Govitecan in Resistant Advanced Urothelial Carcinoma

byDaniel Goldshteinand1 others

February 5, 2024

1. The objective response rate was 28% with a complete response of 5.6% and a partial response of 23%. 2. ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

2 Minute Medicine Rewind October 12, 2026
Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections
Most routine blood tests do not require prolonged fasting

No Result

View All Result

Tag: UGT1A

Updated Outcomes of Sacituzumab Govitecan in Resistant Advanced Urothelial Carcinoma

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits